The only way to cure Alzheimer’s is through clinical trials.

July 22, 2017
00:0000:00

 

Dwyer-Headshot-Web-e1461693382108-300x298.jpg

 

John Dwyer, President and Founding Board Member of the Global Alzheimer’s Platform Foundation that is dedicated to speeding the delivery of innovative medicines to those in need by reducing the time and cost of Alzheimer’s disease clinical trials joins eHealth Radio and the Alzheimer's Information & Health News Channels.

 

Listen to interview with host Eric Michaels and guest John Dwyer discuss the following:

  • What is the state of Alzheimer’s disease in this country:
  • What do treatments look like for those affected?
  • How many people are predicted to develop Alzheimer’s in the next 5 years, 10 years, 20 years
  • If Alzheimer’s will become an epidemic, why haven’t we found a cure yet?
  • What is the Global Alzheimer’s Platform Foundation (GAP Foundation)?
  • Explain, in a general sense, how a clinical trial works and how the GAP Foundation plans to help speed this process?
  • Minorities are being underrepresented in clinical trials. Why do we need to get more African Americans and Hispanics involved in clinical trials?
  • What can people do now to help in the fight against Alzheimer’s disease?

 

John R. Dwyer, Jr. is the President of the Global Alzheimer’s Platform Foundation. The GAP Foundation is dedicated to making the clinical trial process for Alzheimer’s therapies substantially more efficient thereby speeding cures to patients afflicted with this insidious disease.

John is a serial healthcare entrepreneur who most recently participated in the acquisition of MeYou Health, upon whose Board he now serves.  Prior to GAP, John served as the co-founder and Chairman of Telcare, Inc., a high technology manufacturer of the first wirelessly enabled blood glucose meter designed to empower patients with diabetes to better manage their disease.

Mr. Dwyer first became a CEO at the age of 30. In the following years, he has held “C” level positions in six emerging growth companies in the healthcare industry. His past assignments have included serving as CEO of e-Medex, Inc., which later merged with Active Health Management to become the leading provider of population health management services where he served as the Chief Operating Officer. Active Health was purchased by Aetna in 2005. He was also a co-founder and Chairman of CodeRyte, Inc., a venture-backed seller of medical billing software using natural language processing to generate billing codes.  CodeRyte was purchased by 3M in 2012.

Mr. Dwyer co-founded Us Against Alzheimer’s, a patient advocacy group focused on changing the way the country addresses the threat posed by Alzheimer’s.  He also co-founded the first political action committee focused on a specific disease, the Alzheimer’s Action PAC.   He began his career as an attorney with the Washington DC based law firm of Arent, Fox LLP where he focused on transactions in regulated industries.

Mr. Dwyer is a frequent speaker on financing and regulatory issues of critical importance to emerging health technology companies. He also regularly speaks on health information issues and the business risks associated with the regulatory and payer process.

Mr. Dwyer currently serves on the Boards of Directors of a number of private and not-for-profit organizations. Mr. Dwyer is a graduate of Marquette University and the Cornell Law School.

 

GAPlogo.png

Websites: www.globalalzplatform.org | www.memorystrings.org

Facebook Comments: